
Qxone S 250mg/125mg Injection
Marketer
Anista Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Qxone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a medical professional. Strict adherence to the prescribed dosage schedule is crucial; premature cessation may compromise treatment efficacy. Complete the full course, even with symptom improvement. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms to your physician immediately. Seek prompt medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, proper nutrition, and hydration are essential for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Qxone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Qxone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Qxone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Qxone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Qxone S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Qxone S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by counteracting bacterial resistance mechanisms, thereby improving its effectiveness.
SAFETY ADVICE
AlcoholSAFE
Qxone S 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Qxone S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administration of Qxone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Qxone S 250mg/125mg Injection can lead to drowsiness, visual disturbances, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Qxone S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable medication Qxone S 250mg/125mg requires careful administration for individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Qxone S 250mg/125mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Qxone S 250mg/125mg Injection :
Forgetting a dose of Qxone S 250mg/125mg Injection? Seek advice from your physician.
Facts to Know About Qxone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
